Participation in the Global and German Biotech Reports 2008 @ EY
Immunology Postdoc in the lab of nobel laureate Prof. Rolf M. Zinkernagel and Prof. Hans Hengartner @ Universitätsspital Zürich
Bruno Eschli's Education
London Business School
(HORIZONS program Roche)
2016 - 2017
Eidgenössische Technische Hochschule Zürich
Dr. sc. ETHZ (Biochemistry, Immunology, Virology)
2002 - 2006
Eidgenössische Technische Hochschule Zürich
Dipl. Natw. ETHZ (Biology)
2000 - 2002
Rockefeller University
Research Internship (Biochemistry, Biophysics and Molecular Biology)
1999 - 2000
University of Tübingen
Undergraduate studies (Biochemistry)
1997 - 1999
Bruno Eschli's Skills
Private Equity
Business Strategy
Portfolio Management
Financial Modeling
Capital Markets
Contract Manufacturing
Investment Banking
Emerging Markets
Investments
Pharmaceutical Industry
Bruno Eschli's Summary
Bruno Eschli, based in Basel, BS, CH, is currently a Head of Investor Relations Roche at Roche, bringing experience from previous roles at Roche, Bank am Bellevue AG and Ernst & Young (European Life Science Center), Mannheim. Bruno Eschli holds a 2016 - 2017 London Business School. With a robust skill set that includes Private Equity, Business Strategy, Portfolio Management, Financial Modeling, Capital Markets and more, Bruno Eschli contributes valuable insights to the industry. Bruno Eschli has 2 emails on RocketReach.